Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. 2001

E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
Intrinsic Bioprobes, Inc., Tempe, Arizona 85281, USA.

A high-throughput mass spectrometric immunoassay (MSIA) system for the analysis of proteins directly from biological fluids is reported. A 96-well-format robotic workstation equipped with antibody-derivatized affinity pipet tips was used for the parallel extraction of specific proteins from samples and subsequent deposition onto 96-well arrayed matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) targets. Interferences from nonspecifically bound proteins were minimized through choice of appropriate affinity pipet tip derivatization chemistries. Sample preparation for MALDI-TOFMS was enhanced through the use of hydrophobic/hydrophilic contrasting targets, which also presented functionalities found to promote matrix/analyte crystal growth. Automated mass spectrometry was used in the unattended acquisition of data, resulting in an analysis rate of approximately 100 samples/h (biological fluid-->data). The quantitative MSIA of beta2m levels present in human plasma samples is given as illustration.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D019032 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted,MALD-MS,MALDI,Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization,Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization,Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry,Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization,MALDI-MS,MS-MALD,SELDI-TOF-MS,Surface Enhanced Laser Desorption Ionization Mass Spectrometry,Laser Desorption Ionization Mass Spectrometry, Matrix Assisted,MALDI MS,Mass Spectrometry, Matrix Assisted Laser Desorption Ionization,Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization,Matrix Assisted Laser Desorption Ionization Mass Spectrometry

Related Publications

E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
February 2001, Analytical biochemistry,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
February 1986, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
August 1988, The British journal of dermatology,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
January 1984, Acta haematologica,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
December 1992, Clinical chemistry,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
August 1980, Annals of the rheumatic diseases,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
June 1981, Clinical chemistry,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
December 2023, Analytical chemistry,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
August 1988, Arzneimittel-Forschung,
E E Niederkofler, and K A Tubbs, and K Gruber, and D Nedelkov, and U A Kiernan, and P Williams, and R W Nelson
December 1983, The Journal of rheumatology,
Copied contents to your clipboard!